Shree Ganesh Remedies Limited is an India-based company, which is engaged in the business of bulk drug intermediates. The Company's products include intermediates by active pharmaceutical ingredient (API), and fine and specialty chemicals. Its human health API intermediates include antipsychotic, antidepression, oncology, diabetic, and diuretic. Its specialty & fine chemicals include aroma & health industry, agro-industry, polymer industry, and electronics industry. Its veterinary API intermediates include feed additives, antiparasitic, and anti-inflammatory. Its anti-arrhythmic API intermediates include amiodarone intermediates, dronedarone intermediates, and mesalazine intermediates. Its anti-cancer API intermediates include cabozantinib intermediates, gefitinib intermediates, olaparib intermediates, and raloxifene intermediates. Its anti-parasitic API intermediates include flubendazole intermediates, nitazoxanide intermediates, and praziquantel intermediates.As of 26 May 2026, Shree Ganesh Remedies Limited share price is ₹653.00. The stock opened at ₹632.00, compared to its previous close of ₹622.30. During today's trading session, Shree Ganesh Remedies Limited share price moved in the range of ₹621.30 to ₹658.00, with an average price of ₹639.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹621.30 and a high of ₹658.00.
The market capitalization of Shree Ganesh Remedies Limited is ₹799 Crs, with a P/E ratio of 45.0 and a dividend yield of 0.00%.